HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop ...
SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative therapies for high incidence immuno-dermatological ...
Black Book Research, the trusted independent evaluator of healthcare IT solutions, has named ClinicMind the top-ranked vendor for Chiropractic Electronic Health Records (EHR) and Practice Management ...
VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed ...
There are approximately 385,000 needlestick and sharps-related injuries among healthcare workers each year in the U.S., based on CDC reports. ORLANDO, FLORIDA / ACCESSWIRE / January 9, 2025 / With the ...
The Certification Joins Quest's 4 Existing ISO Registrations to Form the Industry's Most Complete Quality Management System IRVINE, CALIFORNIA / ACCESSWIRE / January 9, 2025 / Quest International, the ...
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system.
Three customers take delivery at year endVANCOUVER, BC / ACCESSWIRE / January 9, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth ...
Exclusive Distributor to Drive International Growth in Chile, Argentina, Peru and Colombia LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / Med-X, Inc., a leading innovator of all-natural green scene ...
Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback